EcoR1 Capital LLC 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 0 0.000% |
-4,368,500 (Position Closed) |
Filing |
| 2021-01-26 12:21 pm Purchase |
2021-01-22 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 4,368,500 6.800% |
4,368,500 (New Position) |
Filing |